Alloplex Biotherapeutics

Alloplex Biotherapeutics, Inc. is a privately held clinical-stage cellular immunotherapy company founded in 2016 and headquartered in Woburn, Massachusetts, with a wholly owned subsidiary, Alloplex Australia Pty Ltd, in Adelaide, South Australia. It develops non-engineered, autologous multi-cellular therapies intended to retrain a patient's own immune system against solid tumors and autoimmune disease. Its ENLIST platform uses an irradiated, engineered melanoma cell line expressing multiple immunomodulatory factors to activate, differentiate and expand a patient's peripheral blood mononuclear cells; the resulting product, SUPLEXA, is manufactured by a defined, GMP-compatible process that uses no genetic engineering and no feeder cells and yields a full course of treatment from a small blood draw in roughly one month. The first-in-human Phase 1 SUPLEXA-101 trial, conducted in Australia in 35 patients with metastatic solid tumors who had exhausted standard options, met its endpoints, and the FDA granted SUPLEXA Fast Track designation for MSI-H colorectal cancer. Alloplex Biotherapeutics runs no developer program and publishes no product API, developer portal, SDK or API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind alloplexbio.com, catalogued here.

Alloplex Biotherapeutics publishes 7 APIs on the APIs.io network, including Discovery API, Media API, Oembed API, and 4 more. Tagged areas include Company, biotechnology, cell-therapy, immunotherapy, and oncology.

The Alloplex Biotherapeutics catalog on APIs.io includes 1 JSON-LD context.

Alloplex Biotherapeutics’ developer surface includes product news, engineering blog, FAQ, support, authentication, and 27 more developer resources.

🌐 Visit website 📡 Source on GitHub

34.9/100 thin ▬ flat Agent 33/100 agent aware Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0

7 APIs

Companybiotechnologycell-therapyimmunotherapyoncologycancerclinical-trialslife-sciencesdrug-developmentautoimmunitycontent-api

Kin Score

Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0

Composite quality — 34.9/100 · thin

Contract Quality 13.0 / 21

Developer Ergonomics 3.2 / 17

Commercial Clarity 5.8 / 17

Operational Transparency 0.0 / 11

Governance 1.2 / 10

Discoverability 6.9 / 9

Regulatory Posture 4.7 / 15

Agent readiness — 33/100 · agent aware

Machine-Readable Contract 18 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 10 / 10

Idempotency 0 / 9

Stable Error Semantics 8 / 8

Request/Response Examples 7 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 5 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alloplex-biotherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 7

Individual APIs this provider publishes, each with its own machine-readable definition.

Get Started 1

Portal, sign-up, and the first successful call

Login

Agent Surfaces 3

MCP servers, agent skills, and machine-readable catalogs

WellKnown

WellKnown

LLMsTxt

LLMsTxt

AgentSkill

AgentSkill

Design & Contract 6

Pagination, idempotency, versioning, errors, and events

Conventions

Conformance

ErrorCatalog

Lifecycle

DataModel

JSONLD

Access & Security 2

Authentication, authorization, and security posture

Authentication

Authentication

DomainSecurity

DomainSecurity

Operate 3

Status, limits, changes, and where to get help

FAQ

FAQ

Contact

Contact

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 8

The organization behind the API

Website

About

Investors

News

Blog

BlogRSS

InTheNews

LinkedIn

Scroll for all 8

Other 7

Properties that don't map to a standard resource type

Overlay

Science

MediaKit

Publications

InformationForPatients

InformationForPatients

Sitemap

Sitemap

SecondaryMarket

SecondaryMarket

Scroll for all 7

Source (apis.yml)

aid: alloplex-biotherapeutics
name: Alloplex Biotherapeutics
description: Alloplex Biotherapeutics, Inc. is a privately held clinical-stage cellular immunotherapy company founded in 2016
  and headquartered in Woburn, Massachusetts, with a wholly owned subsidiary, Alloplex Australia Pty Ltd, in Adelaide, South
  Australia. It develops non-engineered, autologous multi-cellular therapies intended to retrain a patient's own immune system
  against solid tumors and autoimmune disease. Its ENLIST platform uses an irradiated, engineered melanoma cell line expressing
  multiple immunomodulatory factors to activate, differentiate and expand a patient's peripheral blood mononuclear cells;
  the resulting product, SUPLEXA, is manufactured by a defined, GMP-compatible process that uses no genetic engineering and
  no feeder cells and yields a full course of treatment from a small blood draw in roughly one month. The first-in-human Phase
  1 SUPLEXA-101 trial, conducted in Australia in 35 patients with metastatic solid tumors who had exhausted standard options,
  met its endpoints, and the FDA granted SUPLEXA Fast Track designation for MSI-H colorectal cancer. Alloplex Biotherapeutics
  runs no developer program and publishes no product API, developer portal, SDK or API documentation; the only machine-readable
  surface reachable without credentials is the WordPress REST content API behind alloplexbio.com, catalogued here.
image: https://alloplexbio.com/wp-content/uploads/2021/05/mark@2x.png
url: https://raw.githubusercontent.com/api-evangelist/alloplex-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- biotechnology
- cell-therapy
- immunotherapy
- oncology
- cancer
- clinical-trials
- life-sciences
- drug-development
- autoimmunity
- content-api
apis:
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-discovery-api
  name: Alloplex Biotherapeutics Discovery API
  description: Route, type, taxonomy and status discovery documents.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - discovery
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-media-api
  name: Alloplex Biotherapeutics Media API
  description: Media library (225 attachments at harvest time), including PDF executive summaries and press assets.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - media
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-media-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-oembed-api
  name: Alloplex Biotherapeutics Oembed API
  description: oEmbed 1.0 provider endpoint for alloplexbio.com URLs.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - oembed
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-oembed-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-pages-api
  name: Alloplex Biotherapeutics Pages API
  description: Corporate pages (19 published at harvest time) — About, Investors, Scientists, Information for Patients, Media
    and Press, Media Kit, FAQ, Releases and Updates, Terms of use, Privacy Policy, Contact, and the shareholder-portal pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - pages
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-pages-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-posts-api
  name: Alloplex Biotherapeutics Posts API
  description: Press releases, scientific and clinical news, conference notes and opinion pieces (61 published at harvest
    time). Unlike many corporate WordPress deployments, content.rendered and excerpt.rendered are fully populated here.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - posts
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-posts-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-search-api
  name: Alloplex Biotherapeutics Search API
  description: Cross-content search across published posts and pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - search
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-search-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-taxonomy-api
  name: Alloplex Biotherapeutics Taxonomy API
  description: Categories and tags. Categories holds 11 terms (company-news, clinical-news, scientific-news, research-news,
    conferences, media-coverage, opinion, backgrounder, diary-marker, audio-video, uncategorized); the tags taxonomy is registered
    but empty (0 terms).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - taxonomy
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-taxonomy-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/alloplex-biotherapeutics-content-overlay.yaml
- type: Website
  url: https://alloplexbio.com/
- type: About
  url: https://alloplexbio.com/about/
- type: Science
  url: https://alloplexbio.com/scientists/
- type: Investors
  url: https://alloplexbio.com/investors/
- type: News
  url: https://alloplexbio.com/newsroom/
- type: Blog
  url: https://alloplexbio.com/releases-and-updates/
- type: BlogRSS
  url: https://alloplexbio.com/feed/
- type: InTheNews
  url: https://alloplexbio.com/in-the-news/
- type: MediaKit
  url: https://alloplexbio.com/presskitoct24/
- type: Publications
  url: https://alloplexbio.com/publications/
- type: InformationForPatients
  url: https://alloplexbio.com/information-for-patients/
- type: FAQ
  url: https://alloplexbio.com/faq/
- type: Contact
  url: https://alloplexbio.com/contact/
- type: Support
  url: https://alloplexbio.com/contact/
- type: Login
  url: https://alloplexbio.com/portal-login/
- type: TermsOfService
  url: https://alloplexbio.com/terms/
- type: PrivacyPolicy
  url: https://alloplexbio.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/alloplex-biotherapeutics
- type: Sitemap
  url: https://alloplexbio.com/sitemap_index.xml
- type: SecondaryMarket
  url: https://forgeglobal.com/alloplex-biotherapeutics_stock/
- type: Authentication
  url: authentication/alloplex-biotherapeutics-authentication.yml
- type: Conventions
  url: conventions/alloplex-biotherapeutics-conventions.yml
- type: Conformance
  url: conformance/alloplex-biotherapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/alloplex-biotherapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/alloplex-biotherapeutics-lifecycle.yml
- type: DataModel
  url: data-model/alloplex-biotherapeutics-data-model.yml
- type: JSONLD
  url: json-ld/alloplex-biotherapeutics-json-ld.yml
- type: WellKnown
  url: well-known/alloplex-biotherapeutics-well-known.yml
- type: DomainSecurity
  url: security/alloplex-biotherapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/alloplex-biotherapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-06'
  status: enriched
  artifacts_added: 17
  pass: local-v1
x-coverage:
  state: covered
  reason: no-developer-program
  detail: Alloplex Biotherapeutics is a clinical-stage biotech that runs no developer program — /developers/, /api/ and every
    /.well-known/ path return 404 against a verified negative control — but its corporate WordPress site exposes a genuinely
    anonymous, machine-readable REST content API at /wp-json/ (61 posts, 19 pages, 225 media items, populated content bodies),
    which is what this profile catalogues; the site also registers a WordPress MCP adapter and the Abilities API, but both
    return 401 rest_forbidden anonymously so no agent surface is claimed.
  evidence:
  - url: https://alloplexbio.com/wp-json/
    status: 200
  - url: https://alloplexbio.com/wp-json/wp/v2/posts?per_page=1
    status: 200
  - url: https://alloplexbio.com/wp-json/mcp/mcp-adapter-default-server
    status: 401
  - url: https://alloplexbio.com/.well-known/agent-card.json
    status: 404
  - url: https://alloplexbio.com/openapi.json
    status: 404
  - url: https://alloplexbio.com/.well-known/THIS-SHOULD-404-control
    status: 404
  checked: '2026-08-06'

Alloplex Biotherapeutics

Kin Score

APIs 7

Alloplex Biotherapeutics Discovery API

Alloplex Biotherapeutics Media API

Alloplex Biotherapeutics Oembed API

Alloplex Biotherapeutics Pages API

Alloplex Biotherapeutics Posts API

Alloplex Biotherapeutics Search API

Alloplex Biotherapeutics Taxonomy API

Semantic Vocabularies 1

Alloplex Biotherapeutics Organization Context

Security Posture 2

Alloplex Biotherapeutics Authentication

Alloplex Biotherapeutics Domain Security

Resources